Open AccessIncidence of endophthalmitis after intravitreal Anti-vascular endothelial growth factor: Experience in Saudi Arabia
Author(s) -
Saba Al-Rashaed,
Sulaiman M. Alsulaiman,
Abdulaziz Adel Alrushood,
Jluwi Almasaud,
J. Fernando Arévalo
Publication year - 2015
Publication title -
middle east african journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.357
H-Index - 25
eISSN - 0975-1599
pISSN - 0974-9233
DOI - 10.4103/0974-9233.171756
Subject(s) - medicine , endophthalmitis , ranibizumab , vitrectomy , bevacizumab , pars plana , incidence (geometry) , ophthalmology , visual acuity , surgery , evisceration (ophthalmology) , chemotherapy , physics , alternative medicine , pathology , optics
To report the incidence of endophthalmitis, the clinical and microbiological aspects, after intravitreal (IVT) injection of anti-vascular endothelial growth factor.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom